10MD attracts capital

Jun 30, 2017

10MD has raised capital in a funding round to a few selected private investors. The funding will primarily be used to scale up production capacity of NAFT.

Ten Medical Design AB (10MD) is a medical technology company committed to providing innovative products to healthcare professionals. In February 2017, the developed radiation protection material NAFT fulfilled technical requirements and passed conformity tests in radiation protection at the test institute Physikalisch-Technische Bundesanstalt in Germany.

10MD has raised capital in a funding round to a few selected private investors. The issue of shares was closed in June 30 and enables 10MD to scale up production of NAFT. 

- "Increasing production capacity of NAFT is an important step towards delivering on market demands ", says Mr Fredrik Gellerstedt, CEO of 10MD.

 

For more information, please contact petra.apell@10md.se.